24 results
8-K
p61 hgxdc1v
9 Aug 21
Arcturus Therapeutics Announces Second Quarter 2021 Financial Results and mRNA Vaccine and Therapeutics Pipeline Progress
4:02pm
8-K
EX-99.1
r5q xhauufxi
9 Aug 21
Arcturus Therapeutics Announces Second Quarter 2021 Financial Results and mRNA Vaccine and Therapeutics Pipeline Progress
4:02pm
8-K
w74uqdeshowzff66z8
4 Aug 21
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-99.1
opeevn08tmo3 iye6
10 May 21
Arcturus Therapeutics Announces First Quarter 2021 Company Overview and Financial Results and Provides New Clinical Data
4:21pm
8-K
EX-99.1
gy6di9j6ck
1 Mar 21
Arcturus Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Positive Clinical Updates
4:20pm
8-K
j52g18gjmi0708 9xhg5
3 Feb 21
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
1:00pm
424B5
sx16rjx1
8 Dec 20
Prospectus supplement for primary offering
5:30pm
424B5
cr6kpfy3
7 Dec 20
Prospectus supplement for primary offering
5:20pm